Daix (France), New York City (New York, United States), October 14, 2025 – Inventiva (Euronext Paris and Nasdaq : IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on…
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of…
Veteran corporate advisor to strengthen governance, oversight, and strategic execution as the Company advances late-stage programs WESTLAKE VILLAGE, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) — Turn Therapeutics (“Turn” or the…
DENVER, Oct. 14, 2025 (GLOBE NEWSWIRE) — All the buzz around technology today is centered on Artificial Intelligence, Robotics, Digital Currency ($BTC), and the rare earth minerals used to build…
SAN LEANDRO, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) — ZymoChem, the materials company decarbonizing the chemical industry through biological manufacturing, announces its recognition as a Startup of the Year by…
Dewpoint will present one poster at AACR-NCI-EORTC MYC is a highly desirable oncogenic target that historically eluded drug hunters Small molecules that inhibit the oncogenic function of MYC were discovered…
Press Release EVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseases Through this funding round, the company will initiate the clinical development of its first therapeutic candidate, EVerGel, in…
First-in-class regenerative therapy for diabetic foot ulcers complicated by peripheral artery disease Celularity PDA-002 achieved durable wound healing with just two intramuscular doses As a qualified stem cell therapy under…
LOS ANGELES, CA, Oct. 14, 2025 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that it…
CLR 225 (225Ac-phospholipid ether) Demonstrates Meaningful Inhibition of Tumor Growth and Potential Survival Benefit In Three Pancreatic Cancer Xenograft Models FLORHAM PARK, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) — Cellectar…